ADC Joint Venture (with Alloy Therapeutics)

About Tahoe Therapeutics

Tahoe Therapeutics is a San Francisco-based biotech startup, founded in 2021, that is pioneering a data-centric AI approach to drug discovery. The company's core asset is its generation of massive, proprietary single-cell datasets that capture how chemical and genetic perturbations affect cell biology, which are used to train predictive AI models. This platform aims to de-risk and accelerate the identification of novel therapeutics, particularly for hard-to-treat cancers, as evidenced by an active partnership to develop antibody-drug conjugates. Tahoe operates with an open-science ethos, having released a 100-million-cell dataset, and is backed by significant venture funding and collaborations with leading research institutes.

Therapeutic Areas

Other Hard-to-Treat Cancers Drugs